These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37432399)
1. Veratricplatin inhibits the progression of hypopharyngeal squamous cell carcinoma FaDu cells in vitro and in vivo. Wang D; Wu H; Wu Q; Liu Q; Li Y; Wu J; Nie J Cancer Chemother Pharmacol; 2023 Sep; 92(3):211-221. PubMed ID: 37432399 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anti-tumor activity of Coenzyme Q Yang HL; Chiu LW; Lin YA; Pandey S; Vadivalagan C; Liao JW; Gowrisankar YV; Chen HJ; Lin HY; Hseu YC Toxicol Appl Pharmacol; 2023 Apr; 465():116453. PubMed ID: 36914119 [TBL] [Abstract][Full Text] [Related]
3. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo. Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239 [TBL] [Abstract][Full Text] [Related]
4. Nimesulide inhibited the growth of hypopharyngeal carcinoma cells via suppressing Survivin expression. Jia-Jun T; Su-Mei L; Liang Y; Ju-Ke M; Ya-Kui M; Hai-Bo W; Wei X Head Neck Oncol; 2012 Mar; 4():7. PubMed ID: 22453101 [TBL] [Abstract][Full Text] [Related]
5. 5-aza-2'-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line. Miari R; Azzam N; Bar-Shalom R; Fares F PLoS One; 2021; 16(9):e0253756. PubMed ID: 34534222 [TBL] [Abstract][Full Text] [Related]
6. The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models. Clémenson C; Jouannot E; Merino-Trigo A; Rubin-Carrez C; Deutsch E Invest New Drugs; 2013 Apr; 31(2):273-84. PubMed ID: 22810221 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma: Riestra-Ayora J; Sánchez-Rodríguez C; Palao-Suay R; Yanes-Díaz J; Martín-Hita A; Aguilar MR; Sanz-Fernández R Drug Deliv; 2021 Dec; 28(1):1376-1388. PubMed ID: 34180747 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. Tyagi A; Gu M; Takahata T; Frederick B; Agarwal C; Siriwardana S; Agarwal R; Sclafani RA Clin Cancer Res; 2011 Aug; 17(16):5402-11. PubMed ID: 21705453 [TBL] [Abstract][Full Text] [Related]
9. Phenformin Induces Caspase-dependent Apoptosis of FaDu Head and Neck Squamous Cell Carcinoma Cells. Seo YS; Kim TH; Lim H; Oh JS; You JS; Lee GJ; Yu SK; Kim DK; Kim HJ; Kim CS; Lee SY; Kim SG; Kim JS Anticancer Res; 2019 Jul; 39(7):3499-3506. PubMed ID: 31262874 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anti-tumor activity of Antrodia salmonea against twist-overexpressing HNSCC cells: Induction of ROS-mediated autophagic and apoptotic cell death. Yang HL; Lin YA; Pandey S; Liao JW; Way TD; Yeh YL; Chen SJ; Hseu YC Food Chem Toxicol; 2023 Feb; 172():113564. PubMed ID: 36563924 [TBL] [Abstract][Full Text] [Related]
11. Costunolide enhances cisplatin-induced cytotoxicity in hypopharyngeal SCC FaDu cells by increasing the production of reactive oxygen species. Li J; Duan B; Cheng Z; Kou M Pathol Res Pract; 2022 Aug; 236():153966. PubMed ID: 35679753 [TBL] [Abstract][Full Text] [Related]
12. Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells. Seo YS; Yim MJ; Kim BH; Kang KR; Lee SY; Oh JS; You JS; Kim SG; Yu SJ; Lee GJ; Kim DK; Kim CS; Kim JS; Kim JS Oncol Rep; 2015 Dec; 34(6):3025-34. PubMed ID: 26503508 [TBL] [Abstract][Full Text] [Related]
13. Tunicamycin-induced endoplasmic reticulum stress inhibits chemoresistance of FaDu hypopharyngeal carcinoma cells in 3D collagen I cultures and in vivo. Gu C; Zhang Y; Chen D; Liu H; Mi K Exp Cell Res; 2021 Aug; 405(2):112725. PubMed ID: 34224701 [TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line. Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983 [TBL] [Abstract][Full Text] [Related]
15. VE-822 Enhanced Cisplatin Chemotherapy Effects on Head and Neck Squamous Cell Carcinoma Drug-resistant Cells. Chen T; Yang F; Dai X; Yu Y; Sun Y; Wu X; Li R; Zhou Q Curr Cancer Drug Targets; 2023; 23(6):482-495. PubMed ID: 36748213 [TBL] [Abstract][Full Text] [Related]
16. 3-MA Enhanced Chemosensitivity in Cisplatin Resistant Hypopharyngeal Squamous Carcinoma Cells via Inhibiting Beclin -1 Mediated Autophagy. Zhang J; Mao W; Liu Y; Ding J; Wang J; Yu Z; Huang R; Yang S; Sun Y; Dong P Curr Pharm Des; 2021; 27(7):996-1005. PubMed ID: 33349212 [TBL] [Abstract][Full Text] [Related]
17. Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines. Atri S; Nasoohi N; Hodjat M Curr Mol Pharmacol; 2021; 14(1):60-67. PubMed ID: 32394848 [TBL] [Abstract][Full Text] [Related]
18. Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture. Roomi MW; Roomi NW; Kalinovsky T; Rath M; Niedzwiecki A Integr Cancer Ther; 2009 Jun; 8(2):168-76. PubMed ID: 19679626 [TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma. Scher RL Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613 [TBL] [Abstract][Full Text] [Related]
20. Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma. Schnoell J; Stanisz I; Jank BJ; Stanek V; Schmid R; Brunner M; Heiduschka G; Kotowski U Invest New Drugs; 2022 Apr; 40(2):224-231. PubMed ID: 34613571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]